Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/19/2000US6162826 Genipin derivative having anti hepatitis B virus activity
12/19/2000US6162822 Bisimide compounds
12/19/2000US6162820 Method for removing parasites and in particular ectoparasites of vertebrates, in particular of mammals, and compositions for the implementation of this method
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162817 Stroke therapy; brain disorders; crohn's disease
12/19/2000US6162816 Antisecretory, antiulcer agents
12/19/2000US6162815 Hyperglycemia
12/19/2000US6162813 Antagonists of gonadotropin releasing hormone
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162811 Antitumor agents
12/19/2000US6162809 Pyridylthio compounds for controlling helicobacter bacteria
12/19/2000US6162808 Compounds
12/19/2000US6162807 Thio acid derived monocyclic N-heterocyclics as anticoagulants
12/19/2000US6162806 Oxygen scavenger
12/19/2000US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity
12/19/2000US6162802 Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
12/19/2000US6162801 Eye drops for prevention of keratoconjunctivitis with vitamin d
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162793 Bactericides and antibiotics
12/19/2000US6162792 Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162774 Mixture of salicylic acid, maleic acid and pyruvic acid with detergent base
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162479 Citrus based spiro ethers as anti-fast-pass effect agents used as dietary supplement or medical food
12/19/2000US6162467 Sustained release compositions and a method of preparing pharmaceutical compositions
12/19/2000US6162464 Non-aqueous colonic purgative formulations
12/19/2000US6162463 Extended release formulation of diltiazem hydrochloride
12/19/2000US6162462 Incubating a bupivacaine solution at a controlled ph which prevents its precipitation, with a suspension of giant multivescular liposomes having greater concentration of ammonium ions inside than outside, removing non-capsulated
12/19/2000US6162459 Acyclovir transdermal delivery system
12/19/2000US6162450 Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
12/19/2000US6162445 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
12/19/2000US6162444 Cosmetic or pharmaceutical compositions
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000US6162420 Use of glyceryl triacetate for treating onychomycoses
12/19/2000US6162419 Stabilized ascorbyl compositions
12/19/2000US6162241 Hemostatic tissue sealants
12/19/2000US6161544 Methods for accelerated orthokeratology
12/19/2000US6161536 Dosage form for aerosol administration
12/19/2000CA2234826C Fluoxetine enteric pellets
12/19/2000CA2202989C Method of pretreating an animal with a corticosteroid prior to infusion of a perfluorochemical emulsion
12/19/2000CA2184822C Intranasal antimigraine composition
12/19/2000CA2174658C Novel composition
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/19/2000CA2063791C Hard gelatine capsule containing fat-soluble nutrients.
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/19/2000CA2028629C Antiandrogenically-effective pharmaceutical compositions
12/19/2000CA2014759C Novel steroid derivatives
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/17/2000CA2275049A1 Drug delivery composition for dental applications
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075351A1 Siv-based packaging-defficient vectors
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075162A1 A compound containing a labile disulfide bond
12/14/2000WO2000075158A2 NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
12/14/2000WO2000075156A1 6-o-carbamate ketolide derivatives
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075143A1 Crystals of carbapenem derivatives and pharmaceutical preparations for injection
12/14/2000WO2000075142A2 Dna methyltransferase inhibitors
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075137A1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075136A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075134A1 Pyrazinone thrombin inhibitors
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075130A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000WO2000075127A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075123A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000075120A1 Diaminothiazoles and their use for inhibiting protein kinases
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
12/14/2000WO2000075116A2 Tricyclic analgesics
12/14/2000WO2000075115A1 Pernasal preparations
12/14/2000WO2000075114A1 Beta2-adrenoceptor agonists
12/14/2000WO2000075110A1 Pharmaceutical compositions and methods for use
12/14/2000WO2000075109A1 Ethanesulfonyl-piperidine derivatives
12/14/2000WO2000075108A1 Inhibitors of metalloproteinases
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000075102A1 Excitatory amino acid receptor modulators
12/14/2000WO2000075101A1 Excitatory amino acid receptor modulators
12/14/2000WO2000074933A1 Composite laminate and method for its production
12/14/2000WO2000074784A1 Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074719A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
1 ... 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 ... 7860